Baxter International (NYSE:BAX) Lowered to “Hold” at StockNews.com
StockNews.com lowered shares of Baxter International (NYSE:BAX – Free Report) from a buy rating to a hold rating in a report released on Tuesday. A number of other research analysts also recently commented on BAX. Citigroup raised their target price on shares of Baxter International from $38.00 to $40.00 and gave the company a neutral […]
Owens Corning (NYSE:OC) Stock Rating Lowered by StockNews.com
StockNews.com cut shares of Owens Corning (NYSE:OC – Free Report) from a buy rating to a hold rating in a report published on Tuesday morning. A number of other brokerages have also weighed in on OC. Barclays dropped their price target on Owens Corning from $190.00 to $189.00 and set an equal weight rating on […]
Bank of America (NYSE:BAC) Cut to “Sell” at StockNews.com
StockNews.com lowered shares of Bank of America (NYSE:BAC) from a hold rating to a sell rating in a research report report published on Wednesday morning. Other analysts have also issued reports about the company. Seaport Res Ptn upgraded Bank of America from a hold rating to a strong-buy rating in a research note on Tuesday, […]
StockNews.com Lowers Nomad Foods (NYSE:NOMD) to Hold
StockNews.com downgraded shares of Nomad Foods (NYSE:NOMD – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Several other analysts have also weighed in on NOMD. Barclays lowered their target price on Nomad Foods from $22.00 to $21.00 and set an overweight rating on […]
Rollins (NYSE:ROL) Rating Increased to Buy at StockNews.com
StockNews.com upgraded shares of Rollins (NYSE:ROL – Free Report) from a hold rating to a buy rating in a research note released on Wednesday. A number of other equities analysts also recently issued reports on ROL. Royal Bank of Canada reissued an outperform rating and set a $52.00 target price on shares of Rollins in […]
Baxter International (NYSE:BAX) Price Target Raised to $40.00 at Citigroup
Baxter International (NYSE:BAX – Free Report) had its price objective lifted by Citigroup from $38.00 to $40.00 in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a neutral rating on the medical instruments supplier’s stock. A number of other equities research analysts have also issued reports on the company. JPMorgan Chase […]
last updated on 6 Oct 09:16